Check out this evening’s top movers from around Wall Street, compiled by The Fly.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
HIGHER –
- Processa Pharmaceuticals (PCSA) up 21.8% after announcing it has dosed in Phase 2 clinical trial of NGC-Cap for MBC
- Fidelity National Financial (FNF) up 2.1% after acquiring First Nationwide Title Agency
- Apollo Global Management (APO) up 1.7% after buying minority stake in Vonovia for EUR 1B
- Southwest Airlines (LUV) up 1.7% after insider buying activity
DOWN AFTER EARNINGS –
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PCSA:
- Processa Pharmaceuticals jumps 28% after Phase 2 study update
- Processa: First patient dosed in Phase 2 clinical trial of NGC-Cap for MBC
- Processa Pharmaceuticals reports Q2 EPS ($1.01) vs. ($1.94) last year
- Processa Pharmaceuticals announces preclinical data for NGC-Iri
- Processa Pharmaceuticals price target lowered to $6 from $8 at H.C. Wainwright
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue